Reviews
Part of How women founder funding options score for one £75,000 scenario
Checks before choosing a women founder funding route or provider
Select a women founder funding route or provider with checks for fit, identity, permissions, terms, full cost, accessibility, conflicts and downside.
Only proceed when every hard gate is passed and no hard-gate answer is unknown.
Complete this checklist for one named route and provider. Attach source links and mark unknown rather than guessing. Compare only options that meet every hard gate.
What to take away
- Complete the checklist for one named route and provider, attaching source links and marking unknown rather than guessing.
- Compare only options that meet every hard gate.
- Separate hard-gate failures from preference scores, since a missing permission or unverifiable provider prevents selection.
- Reopen every price, deadline and status source before signing or submitting, and reopen the comparison if a provider changes a material term.
- The founder should retain control of final acceptance, with time to read documents outside a sales call.
- Check the British Business Bank Finance Finder for route options and the FCA Register for provider permissions.
Business and route fit
- The required amount, purpose and usable date are defined.
- Grant, debt, equity and self-funded alternatives were considered.
- Cash flow supports match funding or repayments.
- Ownership and control limits are approved.
- A delayed, reduced and no-funding case is survivable.
The British Business Bank Finance Finder can help a founder explore finance types from purpose, stage and other circumstances. Its output is educational, not a provider approval. Named UK routes to compare include Start Up Loans, Innovate UK's Women in Innovation awards, and specialist women-focused funds from regional enterprise agencies or CDFIs.
Business and route fit checks
- Amount, purpose and usable date defined
- Grant, debt, equity, self-funded considered
- Cash flow supports match funding
- Ownership and control limits approved
- No-funding case is survivable
Eligibility and availability
- The official page says the route is open or confirms the next window.
- England or UK geography matches the business and activity.
- Company stage, sector, size and use of funds fit.
- The women-led definition and mixed-team rule are recorded verbatim in meaning.
- No eligibility statement is inferred from a historic cohort.
For UK schemes, the current women-led eligibility wording is published on the scheme's official GOV.UK page or the provider's own criteria document. Always check the latest version there.
Provider identity and authority
- Legal name, registration and independently found contact agree.
- The application channel was reached from an official source.
- Regulatory permissions were checked where relevant.
- Impersonation warnings and pressure tactics were resolved.
- The final decision maker is clear.
Use the FCA Register for applicable firm, individual, trading-name and permission checks. A positive search is not a guarantee of performance.
Provider identity and authority
- Legal name, registration and contact agree
- Application channel from official source
- Regulatory permissions checked
- Impersonation and pressure tactics resolved
- Final decision maker is clear
Terms and whole cost
- Gross and net usable amounts are separated.
- Interest, fees, commission, VAT and adviser costs are complete.
- Founder and staff time is budgeted.
- Personal liability, security, dilution and governance are visible.
- Reporting, claim, repayment and exit duties have owners.
- Quotes and rates carry a current date.
Service and access
- Required documents and timetable are realistic.
- Accessible completion and requested adjustments are confirmed.
- Privacy purposes, sharing and retention are understood.
- Complaints, correction and cancellation routes are usable.
- Supplier outage and missed-deadline risks have a fallback.
Independence and evidence
- Commissions, affiliate payments, sponsorship and conflicts are disclosed.
- Testimonials are not treated as representative results.
- Outcome claims show denominator, period and finance route.
- Professional advice is independent where the consequence requires it.
Record the decision, rejected alternatives, assumptions, approvers and review date.
Turn answers into a decision note
Begin the note with the business constraint, finance required and latest useful receipt date. List the comparable routes considered and explain any early exclusion. Attach the completed checklist and source date rather than copying terms into a narrative that will age invisibly.
Worked example: a founder compares a £15,000 Start Up Loan over three years at 6% with a £10,000 Innovate UK grant. The loan has net usable cash of £15,000 but a whole cost of about £16,400 including interest and fees.
The grant has net usable cash of £9,000 after £1,000 of eligible costs, and a whole cost of £1,000. These illustrative figures for Start Up Loans and Innovate UK must be rechecked.
Record who prepared, independently checked and approved the decision, plus any advice sought or conflict declared.
Before you act
- Define the required amount, purpose and usable date.
- Confirm the route is open or note the next window.
- Check legal name, registration and contact agree.
- Separate gross and net usable amounts.
- Record commissions, affiliate payments, sponsorship and conflicts.
- Record the decision, approvers and review date.
Common questions
What should I do if a hard-gate answer is still unknown?
If any hard-gate answer is unknown, do not proceed. A missing permission, unverifiable provider, inaccessible essential journey or unaffordable downside prevents selection. Record the decision, rejected alternatives, assumptions, approvers and review date.
How should I handle uncertain facts in my funding case?
Run sensitivity around uncertain facts. Delay receipt, lower the amount, increase professional scope and test no funding. For a personal loan, weaken repayment cash. For equity, change valuation and option assumptions. For a grant, delay reimbursement and remove a disputed cost.
